Molecure SA (MOC) Stock Price & News

MOC:WSE

Molecure SA

PLN 6.72

-3.86%

(-0.27) 1D

Sep 28, 5:00:01 PM GMT+2 · PLN

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Next call in 27:07:10

Wed, Sep 30, 8:30 AM

Fiscal period

Q2 2026

EPS / Est. (PLN)

- / -

Revenue / Est. (PLN)

- / 1.30M

Fiscal Q2 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in PLN

Loading Previous Earnings...

All values in PLN	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	597.71K	2.91M	214.80K	2.95M
Cost of goods sold	686.50K	320.70K	362.37K	21.71M
Cost of revenue	686.50K	320.70K	362.37K	21.71M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.44M	5.51M	4.48M	-14.43M
Operating expense	5.46M	6.34M	5.30M	-16.96M
Total operating expenses	6.15M	6.66M	5.66M	4.75M
Operating income	-5.55M	-3.76M	-5.45M	-1.81M
Other non operating income	-9.26K	78.13K	-	801.03K
EBT including unusual items	-5.18M	-3.51M	-5.27M	-1.73M
EBT excluding unusual items	-5.18M	-3.51M	-5.27M	-1.73M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	244.40K	16.14K	75.87K	-191.15K
Net income	-5.18M	-3.51M	-5.27M	-1.73M
Net profit margin	-867.43%	-120.74%	-2,451.83%	-58.66%
Earnings per share	-	-	-	-
Interest and investment income	399.36K	200.50K	212.00K	40.09K
Interest expense	-5.15K	-14.54K	-30.99K	-811.85K
Net interest expenses	394.20K	185.96K	181.01K	-771.76K
Depreciation and amortization charges	777.57K	811.92K	745.28K	-2.33M
EBITDA	-5.31M	-3.52M	-5.22M	-1.58M
Gain or loss from assets sale	-	-18.95K	-39.50K	58.44K

Finance